Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

Why Do Cancers Have High Aerobic Glycolysis?

Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Prat, A., Parker, J. S., Karginova, O. A., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,290

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798

Glutamine addiction: a new therapeutic target in cancer

Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770

Prospects for ferroptosis therapies in cancer

Ubellacker, J. M., & Dixon, S. J. (2025) · Nature Cancer · doi:10.1038/s43018-025-01037-7 · Cited by 80

Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer.

Sugano, K., Maeda, K., Ohtani, H., Nagahara, H., Shibutani, M., & Hirakawa, K. (2015) · PubMed · Cited by 65

Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer

Beatty, A., Fink, L. S., Singh, T., Strigun, A., Peter, E., Ferrer, C. M., Nicolas, É., Cai, K. Q., Moran, T. P., Reginato, M. J., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0407 · Cited by 67

The CRL3 KCTD10 ubiquitin ligase–USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11

Zhou, Q., Yu, H., Chen, Y., Ren, J., Lü, Y., & Sun, Y. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320655121 · Cited by 67

Deciphering metabolic rewiring in breast cancer subtypes

Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 67

Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer

Wu, W., Sun, H.-W., Chen, J., Ouyang, H., Yu, X.-J., Chen, H., Shuang, Z., Shi, M., Wang, Z., & Zheng, L. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0902 · Cited by 63

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancerin vivo

Bolli, E., O’Rourke, J. P., Conti, L., Lanzardo, S., Rolih, V., Christen, J. M., Barutello, G., Forni, M., Pericle, F., & Cavallo, F. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1408746 · Cited by 66

Glutamine addiction promotes glucose oxidation in triple-negative breast cancer

Quek, L., van Geldermalsen, M., Guan, Y. F., Wahi, K., Mayoh, C., Balaban, S., Pang, A., Wang, Q., Cowley, M. J., Brown, K., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02408-5 · Cited by 63

Current status and prospect of ZIF-based materials for breast cancer treatment

Zeng, Y., Liao, D., Kong, X., Huang, Q., Zhong, M., Liu, J., Nezamzadeh‐Ejhieh, A., Pan, Y. H., & Song, H. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113612 · Cited by 66

Metabolic reprogramming sustains cancer cell survival following extracellular matrix detachment

Endo, H., Owada, S., Inagaki, Y., Shida, Y., & Tatemichi, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101643 · Cited by 64

Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT

Zhou, Y., Yang, J., Chen, C., Li, Z., Chen, Y., Zhang, X., Wang, L., & Zhou, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670224 · Cited by 64

On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer

Penkert, J., Ripperger, T., Schieck, M., Schlegelberger, B., Steinemann, D., & Illig, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11759 · Cited by 64

Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways

van Geldermalsen, M., Quek, L., Turner, N. A., Freidman, N., Pang, A., Guan, Y. F., Krycer, J. R., Ryan, R. M., Wang, Q., & Holst, J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4599-8 · Cited by 62

Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells

Du, J., Wang, L., Huang, X., Zhang, N., Long, Z., Yang, Y. Q., Zhong, F., Zheng, B., Lan, W., Lin, W., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153551 · Cited by 61

A micropeptide XBP1SBM encoded by lncRNA promotes angiogenesis and metastasis of TNBC via XBP1s pathway

Wu, S., Guo, B., Zhang, L., Zhu, X., Zhao, P., Deng, J., Zheng, J., Li, F., Wang, Y., Zhang, S., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02229-6 · Cited by 60

Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis

Wilde, B. R., & Ayer, D. E. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.360 · Cited by 59

Whom to blame for metastasis, the epithelial–mesenchymal transition or the tumor microenvironment?

Pietilä, M., Ivaska, J., & Mani, S. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.033 · Cited by 63

Potential of Diffusion-Weighted Imaging in the Characterization of Malignant, Benign, and Healthy Breast Tissues and Molecular Subtypes of Breast Cancer

Sharma, U., Sah, R. G., Agarwal, K., Parshad, R., Seenu, V., Mathur, S. R., Hari, S., & Jagannathan, N. R. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00126 · Cited by 58

Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo

Shin, S., Jeong, B., Wall, B., Li, J., Shan, N. L., Wen, Y., Goydos, J. S., & Chen, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0098-7 · Cited by 58

Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance

Nwosu, Z. C., Piorońska, W., Battello, N., Zimmer, A. D., Dewidar, B., Han, M., Pereira, S., Blagojevic, B., Castven, D., Charlestin, V., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102699 · Cited by 61

Oncology Therapeutics Targeting the Metabolism of Amino Acids

Muhammad, N., Lee, H. M., & Kim, J. (2020) · Cells · doi:10.3390/cells9081904 · Cited by 59

Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases

Yang, G., Xia, Y., & Ren, W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1703-2 · Cited by 55

SLC6A14, a Na+/Cl−-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling

Sikder, M. O. F., Sivaprakasam, S., Brown, T. P., Thangaraju, M., Bhutia, Y. D., & Ganapathy, V. (2020) · Biochemical Journal · doi:10.1042/bcj20200099 · Cited by 58

Host cell glutamine metabolism as a potential antiviral target

Hirabara, S. M., Gorjão, R., Levada‐Pires, A. C., Masi, L. N., Hatanaka, E., Cury‐Boaventura, M. F., da Silva, E. B., dos Santos-Oliveira, L. C., Diniz, V. L. S., Serdan, T. D. A., et al. (2021) · Clinical Science · doi:10.1042/cs20201042 · Cited by 56

Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles

Zhang, J., Zhou, K., Lin, J., Yao, X., Ju, D., Zeng, X. L., Pang, Z., & Yang, W. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122395 · Cited by 56

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets

Zheng, X., Ma, H., Wang, J., Huang, M., Fu, D., Qin, L., & Yin, Q. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101534 · Cited by 59

Regulation of SLC7A11 as an unconventional checkpoint in tumorigenesis through ferroptosis

Su, Z., Liu, Y., Wang, L., & Gu, W. J. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101254 · Cited by 64

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter

Ruiu, R., Rolih, V., Bolli, E., Barutello, G., Riccardo, F., Quaglino, E., Merighi, I. F., Pericle, F., Donofrío, G., Cavallo, F., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2185-1 · Cited by 52

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer

Singleton, D. C., Dechaume, A.-L., Murray, P. M., Katt, W. P., Baguley, B. C., & Leung, E. Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-06885-3 · Cited by 56

Ultra-small FePt/siRNA loaded mesoporous silica nanoplatform to deplete cysteine for enhanced ferroptosis in breast tumor therapy

Li, Z.-H., Chen, Y., Zeng, X., & Zhang, X. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101150 · Cited by 51

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer

Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57

Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11

Martin, L., & Gardner, L. B. (2014) · Oncogene · doi:10.1038/onc.2014.352 · Cited by 53

Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain

Fazzari, J., Lin, H., Murphy, C., Ungard, R. G., & Singh, G. (2015) · Scientific Reports · doi:10.1038/srep08380 · Cited by 52

Amino Acid Transporters as Disease Modifiers and Drug Targets

Bröer, S. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218755629 · Cited by 53

Glutamine metabolism in cancer therapy

Nguyen, T.-L., & Durán, R. V. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.08 · Cited by 56

Role of the mitochondrial stress response in human cancer progression

Wang, S., Chen, S., Tseng, L., & Lee, H. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220920558 · Cited by 51

Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment

Panetti, S., McJannett, N., Fultang, L., Booth, S., Gneo, L., Scarpa, U., Smith, C. J., Vardon, A., Vettore, L. A., Whalley, C., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008272 · Cited by 52

Discovery and development of small molecule modulators targeting glutamine metabolism

Li, L., Meng, Y., Li, Z., Dai, W., Xu, X. J., Xiao-ling, B., & Bian, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.066 · Cited by 50

Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells

Chakraborty, P., Chatterjee, S., Kesarwani, P., Thyagarajan, K., Iamsawat, S., Dalheim, A. V., Nguyen, H. D., Selvam, S. P., Nasarre, P., Scurti, G. M., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006753 · Cited by 52

Targeting Cell Metabolism as Cancer Therapy

Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 52

The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells

Linher‐Melville, K., & Singh, G. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.014 · Cited by 52

FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity

Yu, L., Wei, W., Lv, J., Yu, L., Wang, Z., & Cai, C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217271 · Cited by 50

Glutamine at focus: versatile roles in cancer

Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 54

SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma

Ma, Z., Zhang, H., Lian, M., Yue, C., Dong, G., Jin, Y., Li, R., Wan, H., Wang, R., Wang, Y., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5976 · Cited by 48

Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma

Shen, L., Qian, C., Cao, H., Wang, Z., Luo, T., & Liang, C. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1535-y · Cited by 47

xCT Inhibition Increases Sensitivity to Vorinostat in a ROS-Dependent Manner

Miyamoto, Κ., Watanabe, M., Boku, S., Sukeno, M., Morita, M., Kondo, H., Sakaguchi, K., Taguchi, T., & Sakai, T. (2020) · Cancers · doi:10.3390/cancers12040827 · Cited by 50

Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells

Yoshida, G. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00791 · Cited by 49

Metabolomic profiling of hormone-dependent cancers: a bird's eye view

Lloyd, S. M., Arnold, J. M., & Sreekumar, A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.07.001 · Cited by 48

Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition

Ulanet, D., Couto, K., Jha, A., Choe, S. E., Wang, Y., Woo, H.-K., Steadman, M., DeLaBarre, B., Größ, S., Driggers, E. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115144 · Cited by 49

Glutamine metabolism: from proliferating cells to cardiomyocytes

Shen, Y., Zhang, Y., Li, W., Chen, K., Xiang, M., & Ma, H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154778 · Cited by 44

Nutrient transporters: connecting cancer metabolism to therapeutic opportunities

Nwosu, Z. C., Song, M. G., di Magliano, M. P., Lyssiotis, C. A., & Kim, S. E. (2023) · Oncogene · doi:10.1038/s41388-023-02593-x · Cited by 51

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

Munkácsy, G., Santarpia, L., & Győrffy, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086945 · Cited by 46

Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring

Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 45

Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism

DeLaBarre, B., Hurov, J., Cianchetta, G., Murray, S., & Dang, L. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.007 · Cited by 45

Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells

Donofrío, G., Tebaldi, G., Lanzardo, S., Ruiu, R., Bolli, E., Ballatore, A., Rolih, V., Macchi, F., Conti, L., & Cavallo, F. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1494108 · Cited by 42

Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer

Morgenroth, A., Tinkir, E., Vogg, A. T. J., Sankaranarayanan, R. A., Baazaoui, F., & Mottaghy, F. M. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1205-1 · Cited by 44

Ferroptosis in cancer therapeutics: a materials chemistry perspective

Guan, Q., Zhou, L., & Dong, Y. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01654g · Cited by 44

Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease

Soomro, I., Sun, Y., Zhai, L., Diggs, L., Hatzivassiliou, G., Thomas, A. G., Rais, R., Slusher, B. S., Somlo, S., & Skolnik, E. Y. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx349 · Cited by 43

Melatonin Alleviates Retinal Ischemia–Reperfusion Injury by Inhibiting p53–Mediated Ferroptosis

Zhang, F., Lin, B., Huang, S., Wu, P., Zhou, M., Zhao, J., Hei, X., Ke, Y., Zhang, Y., & Huang, D. (2023) · Antioxidants · doi:10.3390/antiox12061173 · Cited by 42

NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells

Bottoni, L., Minetti, A., Realini, G., Pio, E., Giustarini, D., Rossi, R., Rocchio, C., Franci, L., Salvini, L., Catona, O., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03025-0 · Cited by 46

mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance

Woo, Y., Lee, H.-J., Jung, Y. M., & Jung, Y. (2019) · Journal of Oncology · doi:10.1155/2019/5956867 · Cited by 42

The role of the glutamine transporter ASCT2 in antineoplastic therapy

Teixeira, E., Silva, C., & Martel, F. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04218-6 · Cited by 42

Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation

Rashid, K., Ahmad, A., Li, L., Liu, M., Cui, Y., & Liu, T. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.004 · Cited by 43

Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis

Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 42

Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer

Wei, Y., Zhu, Z., Hu, H., Guan, J., Yang, B., & Zhao, H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174970 · Cited by 42

Metabolic advantages of regulatory T cells dictated by cancer cells

Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 42

xCT increases tuberculosis susceptibility by regulating antimicrobial function and inflammation

Cai, Y., Yang, Q., Liao, M., Wang, H., Zhang, C., Nambi, S., Wang, W., Zhang, M., Wu, J., Deng, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9052 · Cited by 42

18F-5-Fluoroaminosuberic Acid as a Potential Tracer to Gauge Oxidative Stress in Breast Cancer Models

Yang, H., Jenni, S., Čolović, M., Merkens, H., Poleschuk, C., Rodrigo, I., Miao, Q., Johnson, B. F., Rishel, M. J., Sossi, V., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180661 · Cited by 40

Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management

Lou, J., Zhou, Y., Feng, Z., Ma, M., Yao, Y., Wang, Y., Deng, Y., & Wu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.616952 · Cited by 39

Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors

Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 43

Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment

Fan, Y., Xue, H., Li, Z., Huo, M., Gao, H., & Guan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1345522 · Cited by 40

The amino acid transporter SLC7A11 expression in breast cancer

Nath, P., Alfarsi, L. H., Ansari, R. E., Masisi, B. K., Erkan, B., Fakroun, A., Ellis, I. O., Rakha, E. A., & Green, A. R. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2291855 · Cited by 42

Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight

Savaskan, N. E., Fan, Z., Broggini, T., Buchfelder, M., & Eyüpoglu, I. Y. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150122224158 · Cited by 38

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer

Rolih, V., Caldeira, J. C., Bolli, E., Salameh, A., Conti, L., Barutello, G., Riccardo, F., Magri, J., Lamolinara, A., Parra, K., et al. (2020) · Cancers · doi:10.3390/cancers12061492 · Cited by 39

Intelligent Delivery Systems in Tumor Metabolism Regulation: Exploring the Path Ahead

Li, X., Sun, T., & Jiang, C. (2023) · Advanced Materials · doi:10.1002/adma.202309582 · Cited by 38

Cerebrospinal fluid-based metabolomics to characterize different types of brain tumors

Wang, F., Chen, K., Huang, F., Alolga, R. N., Ma, J., Wu, Z., Fan, Y., Ma, G., & Guan, M. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09665-7 · Cited by 38

Amino Acid Transporters on the Guard of Cell Genome and Epigenome

Kahya, U., Köseer, A. S., & Dubrovska, A. (2021) · Cancers · doi:10.3390/cancers13010125 · Cited by 37

Obesity‐associated biochemical markers of inflammation and the role of grain phytochemicals

Soujanya, K. V., & Jayadeep, A. P. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14257 · Cited by 38

SLC7A11 as a bridge between ferroptosis and disulfidptosis: a promising target for tumor treatment

Qiu, H., Liu, J., Shao, N., Zhao, J., Chen, C., Jiang, Y., Zhao, X., & Xu, L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02447-x · Cited by 48

The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma

Kang, W., Zhang, M., Wang, Q., Gu, D., Huang, Z., Wang, H., Xiang, Y., Xia, Q., Cui, Z., & Jin, X. (2020) · BioMed Research International · doi:10.1155/2020/1932948 · Cited by 37

Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer

Peng, B., Zhang, S.-Y., Chan, K. I., Zhong, Z., & Wang, Y. (2023) · Molecules · doi:10.3390/molecules28020740 · Cited by 39

Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease

Chen, J., Zhang, S., Wu, J., Wu, S., Xu, G., & Wei, D. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.5034 · Cited by 37

Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer

Minatani, N., Waraya, M., Yamashita, K., Kikuchi, M., Ushiku, H., Kojo, K., Ema, A., Nishimiya, H., Kosaka, Y., Katoh, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144862 · Cited by 36

Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer

Wang, Y., Sun, Y., Wang, F., Wang, H., & Hu, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115866 · Cited by 37

Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells

Hernández‐Reséndiz, I., Gallardo‐Pérez, J. C., López-Macay, Á., Robledo‐Cadena, D. X., García-Villa, E., Gariglio, P., Saavedra, E., Moreno‐Sánchez, R., & Rodríguez‐Enríquez, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27354 · Cited by 36

Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review

Wang, D., & Wan, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113923 · Cited by 34

UGCG influences glutamine metabolism of breast cancer cells

Schömel, N., Hancock, S. E., Gruber, L., Olzomer, E. M., Byrne, F. L., Shah, D. P., Hoehn, K. L., Turner, N. A., Grösch, S., Geißlinger, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52169-7 · Cited by 35

Metabolic profiles of regulatory T cells in the tumour microenvironment

Rao, D., Verburg, F., Renner, K., Peeper, D. S., Lacroix, R., & Blank, C. U. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02881-z · Cited by 43

TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury

Wang, A. W., Wangensteen, K. J., Wang, Y. J., Zahm, A. M., Moss, N., Noam Erez, A., & Kaestner, K. H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95120 · Cited by 30

Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment

Wang, L., Peng, W., Wu, T., Deng, P., & Zhao, Y. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0086-x · Cited by 34

Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivatives

Chen, J.-N., Li, T., Cheng, L., Qin, T.-S., Sun, Y., Chen, C.-T., He, Y., Liu, G., Yao, D., Wei, Y., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112661 · Cited by 33

Exploring the Metabolic Vulnerabilities of Epithelial–Mesenchymal Transition in Breast Cancer

Sun, X., Wang, M., Wang, M., Yao, L., Li, X., Dong, H., Li, M., Li, X., Liu, X., & Xu, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00655 · Cited by 38

Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression

Fukano, M., Park, M., & Deblois, G. (2021) · Cancers · doi:10.3390/cancers13184699 · Cited by 36

Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

Greer, Y. E., Hernandez, L. F., Fennell, E. M. J., Kundu, M., Voeller, D. M., Chari, R., Gilbert, S. F., Gilbert, T. S. K., Ratnayake, S., Tang, B., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0142 · Cited by 33

Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer

Wedam, R., Greer, Y. E., Wisniewski, D. J., Weltz, S., Kundu, M., Voeller, D. M., & Lipkowitz, S. (2023) · Cancers · doi:10.3390/cancers15071936 · Cited by 36

Glutamine metabolism regulates FLIP expression and sensitivity to TRAIL in triple-negative breast cancer cells

Mauro-Lizcano, M., & López‐Rivas, A. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0263-0 · Cited by 33

The unique catalytic properties of PSAT1 mediate metabolic adaptation to glutamine blockade

Qiu, Y., Stamatatos, O. T., Hu, Q., Swain, J. D. R., Russo, S., Sann, A., Costa, A. S. H., Violante, S. N., Spector, D. L., Cross, J. R., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01104-w · Cited by 34

Small variations in nanoparticle structure dictate differential cellular stress responses and mode of cell death

Szwed, M., Sønstevold, T., Øverbye, A., Engedal, N., Grallert, B., Mørch, Y. A., Sulheim, E., Iversen, T., Skotland, T., Sandvig, K., et al. (2019) · Nanotoxicology · doi:10.1080/17435390.2019.1576238 · Cited by 34

mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis

Li, C., Chen, H., Zhou, L., He, S., Chen, R., Wang, F., Liu, Z., Li, K., Cheng, L., Liu, Y., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0274-0 · Cited by 33

Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis

Zou, J., Du, K., Li, S., Lu, L., Mei, J., Lin, W., Deng, M., Wei, W., & Guo, R. (2021) · Genes · doi:10.3390/genes12091305 · Cited by 32

Abstract B20: Glutamine metabolic vulnerabilities define triple-negative from luminal A breast cancer subsets

van Geldermalsen, M., Quek, L., Turner, N. A., Balaban, S., Hoy, A. J., Wang, Q., & Holst, J. (2018) · Molecular Cancer Research · doi:10.1158/1557-3125.advbc17-b20

Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation

Long, Y., Xu, Z., Yu, J., Hu, X., Xie, Y., Duan, X., Li, N., Yan, Y., Wang, Y., & Qin, J. (2024) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001630 · Cited by 9

Abstract P3-02-09: Vulnerabilities in glutamine metabolism define triple-negative from Luminal A breast cancer subsets

van Geldermalsen, M., Quek, L., Turner, N. A., Balaban, S., Hoy, A. J., Pang, A., Guan, Y. F., Wahi, K., Wang, Q., & Holst, J. (2020) · Cancer Research · doi:10.1158/1538-7445.sabcs19-p3-02-09

Targeting the ASCT2 glutamine uptake and metabolism pathway in triple-negative breast cancer

van Geldermalsen, M., Wang, Q., Bailey, C. G., Feng, Y., Nagarajah, R., Marshall, A. D., Thoeng, A., O’Toole, S. A., Rasko, J. E. J., & Holst, J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv121.04

Glutamine Transporter Expression Profiling in Murine Breast Cancer Reveals Therapeutic Targets for Triple Negative Breast Cancer

Kron, C., & Bode, B. P. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.809.6